39th week of 2013 patent applcation highlights part 46 |
Patent application number | Title | Published |
20130251770 | Method of Treatment of Wrinkles Using Topical Chemodenervating Agents - Methods for reducing the appearance of wrinkles in a subject are provided herein. The methods of the present invention comprise identifying a wrinkle distribution on a subject and applying a topical composition comprising at least one chemodenervating agent onto and along the wrinkle distribution. The methods disclosed herein provide alternative methods for delivery of chemodenervating agents to the skin for the treatment of wrinkles. | 2013-09-26 |
20130251771 | BRILLIANT BLACK PIGMENTS - The present invention is related to brilliant black pigments comprising a flaky aluminum oxide substrate having a coating comprising a layered structure composed of a hematite and a magnetite layer, to a process for the production of said pigments, as well as to their use. | 2013-09-26 |
20130251772 | Dentifrice Compositions Containing Calcium Silicate - An oral care composition includes an effective amount of calcium silicate particles. The calcium silicate particles have an average diameter of less than about 5 microns, such that they can occlude dentinal tubules of the teeth. An oral care method includes applying the composition to an oral cavity of a subject to reduce or inhibit hypersensitivity of the teeth and to achieve other benefits. | 2013-09-26 |
20130251773 | Controlled Release Insect Repellent Materials - Generally, controlled release insect repellent materials include at least one polymer selected from the group consisting of an ethylene copolymer, an ethyl cellulose, a thermoplastic polyurethane, and any combination thereof and at least one insect repellent and may optionally include at least one insect repellent synergist, at least one additive, at least one additional polymer, and any combination thereof. Further, controlled release insect repellent materials may be used to form articles or products with long-term efficacy. | 2013-09-26 |
20130251774 | BROAD-SPECTRUM ANTIMICROBIAL COMPOSITIONS BASED ON COMBINATIONS OF TAUROLIDINE AND PROTAMINE AND MEDICAL DEVICES CONTAINING SUCH COMPOSITIONS - Novel antimicrobial compositions and coatings are disclosed. The antimicrobial compositions consist of mixtures of taurolidine and protamine, including protamine salts. The antimicrobial compositions are particularly useful in coatings for implantable medical devices. The antimicrobial compositions are effective against a broad spectrum of microbes. | 2013-09-26 |
20130251775 | Pediculicidal process and composition - A pediculicidal process to combat the growth of the louse Pediculus humanus, in which the louse is brought into contact with a composition comprising at least 60% by weight of alkali metal bicarbonate. A parasiticidal process, in which a parasite is brought into contact with a composition in gel form comprising from 40 to 50% by weight of alkali metal bicarbonate particles, from 15 to 25% by weight of silica, and from 35 to 45% of water. In particular, a process for eliminating the louse Pediculus humanus from human hair, in which the head hair is brought into contact for at least 1 hour with the composition in gel form, the operation of bringing into contact for at least 1 hour subsequently being repeated at the earliest two days later. | 2013-09-26 |
20130251776 | Protein Stabilized Antimicrobial Composition Formed by Melt Processing - A method for forming an antimicrobial composition that includes mixing an antimicrobially active botanical oil (e.g., thymol, carvacrol, etc.) and protein within a melt blending device (e.g., extruder) is provided. Despite the problems normally associated with melt processing proteins, the present inventors have discovered that the processing conditions and components may be selectively controlled to allow for the formation of a stable, melt-processed composition that is able to exhibit good mechanical properties. For example, the extrusion temperature(s) and shear rate employed during melt blending are relatively low to help limit polypeptide dissociation, thereby minimizing the impact of aggregation and embrittlement. While the use of such low temperature/shear conditions often tend to reduce mixing efficiency, the present inventors have discovered that a carrier fluid may be employed to enhance the ability of the botanical oil to flow into the internal structure of the protein where it can be retained in a stable manner. The composition is also typically anhydrous and generally free of solvents. In this manner, the protein will not generally disperse before use and prematurely release the botanical oil. | 2013-09-26 |
20130251777 | Brachytherapy Seed - A radiopaque brachytherapy seed for implantation into a subject includes a biocompatible component, a therapeutically active component including a non-radioactive drug, and a radiopaque marker. The biocompatible component is (a) physically associated with a therapeutically active component and (b) in contact with the radiopaque marker. The brachytherapy seed has a size and shape suitable for passing through the bore of a needle having an interior diameter of less than about 2.7 millimeters (10 gauge). | 2013-09-26 |
20130251778 | MEDICAL DEVICES FOR THERAPEUTIC AGENT DELIVERY WITH POLYMERIC REGIONS THAT CONTAIN COPOLYMERS HAVING BOTH SOFT SEGMENTS AND UNIFORM LENGTH HARD SEGMENTS - Implantable or insertable medical devices are described, which include one or more polymeric regions and one or more therapeutic agents. The polymeric regions, which regulate the release of one or more therapeutic agent from the medical device, contain copolymer molecules, each of which includes one or more soft segments and one or more uniform hard segments (e.g., polyamide segments that do not vary in length from molecule to molecule, among others). | 2013-09-26 |
20130251779 | NEW PRODUCT - The invention relates to a nicotine oral delivery product containing a powder enclosed in a water insoluble pouch, wherein said pouch is permeable for saliva and therein dissolved parts of the powder, wherein said powder comprising at least
| 2013-09-26 |
20130251780 | HEMOSTATIC MATERIAL CONTAINING NANO-FIBER CONTAINING SYNTHETIC COLLAGEN - A hemostatic material as a high-performance medical material is described, which is capable of stopping bleeding in short time and is easy to handle and produce. The hemostatic material contains a nano-fiber that contains: a polymer, and a polypeptide having a peptide fragment represented by formula (1): | 2013-09-26 |
20130251781 | Composition and Method for Treating Connective Tissue Damage - The present invention provides a composition, and a method of use thereof, for treating connective tissue damage in man and in animals, which comprises a therapeutically effective amount of chondroitin sulfate, N-acetyl D-glucosamine, and hyaluronan (hyaluronic acid). Particularly, the present invention provides a composition, and a method of use thereof, for treating connective tissue damage including, but not limited to, arthritic disease, osteoarthritis, rheumatoid arthritis, osterochondrosis dessicans, cartilage damage, joint injury, joint inflammation, joint synovitis, degenerative joint disease (DJD), post surgical DJD, traumatic injury, fracture, tendon damage, ligament damage, skeletal damage, musculoskeletal damage, fiber damage, adipose tissue damage, blood cell damage, and plasma damage. Compositions for delivery of the present invention include those for parenteral, oral, and transmucosal delivery and for direct surgical placement onto the affected tissues. | 2013-09-26 |
20130251782 | TOPICAL APPLICATION OF INGENOL MEBUTATE WITH OCCLUSION - The present invention relates to formulations of ingenol mebutate and methods of preparation and use thereof. More specifically, the invention relates to formulations of ingenol-3-mebutate applied to the skin with occlusion, and methods for treating or preventing diseases or conditions. | 2013-09-26 |
20130251783 | LIPOSOMES CONTAINING PERMEATION ENHANCERS FOR ORAL DRUG DELIVERY - The present invention relates to liposomal compositions and their application for delivery of pharmaceuticals for the treatment of disease. | 2013-09-26 |
20130251784 | METHOD FOR IN VIVO TARGETING OF NANOPARTICLES VIA BIOORTHOGONAL COPPER-FREE CLICK CHEMISTRY - The present disclosure relates to a method for in vivo targeting of a nanoparticle via bioorthogonal copper-free click chemistry, more particularly to a method for in vivo targeting of a nanoparticle, including: injecting a precursor capable of being metabolically engineered in vivo when injected into a living system and having a first bioorthogonal functional group into the living system; and injecting a nanoparticle having a second bioorthogonal functional group which can perform a bioorthogonal copper-free click reaction with the first bioorthogonal functional group attached thereto into the living system. | 2013-09-26 |
20130251785 | METHOD AND COMPOSITION FOR TREATING CYSTITIS - A medicament for treating cystitis and a method of treatment are provided. An agent to repair the damaged glycosaminoglycan (“GAG”) layers lining the urothelium, noted in cystitis, such as pentosan polysulfate, hyaluronic acid, chondroitin, etc., is provided in a liposomal carrier. Cystitis is treated by intravesically administering to a patient a therapeutically effective dose of the medicament. | 2013-09-26 |
20130251786 | Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia - Provided are compositions and formulations or co-formulations containing a hyaluronan degrading enzyme. The compositions, formulations or co-formulations can also contain another therapeutic agent, such as one that is suitable for treatment of Benign Prostatic Hyperplasia, for example, a 5-alpha reductase inhibitor. The compositions and formulations can be used for the treatment of Benign Prostatic Hyperplasia. The compositions and formulations can be provided in combinations with one or more other agents for the treatment of Benign Prostatic Hyperplasia. | 2013-09-26 |
20130251787 | Treatment of Pulmonary Hypertension with Leukotriene Inhibitors - Pulmonary arterial hypertension (PAH) can be prevented in persons susceptible to the diseases and PAH patients can be treated by administering an effective dose of a leukotriene inhibitor. Suitable inhibitors include leukotriene A | 2013-09-26 |
20130251788 | Method of Inducing a Phase Transition of a Bilayer Membrane Vesicle - Provided is a bilayer membrane vesicle capable of undergoing a phase transition. The bilayer membrane vesicle includes: (a) a fatty acid salt having 6 to 20 carbon atoms; (b) an alcohol or an amine compound having an aliphatic chain of 6 to 20 carbon atoms; and (c) an artificial synthetic lipid or a phospholipid capable of forming a bilayer membrane. Preferably, this bilayer membrane vesicle further contains (d) a tertiary amine as a component of the membrane. Also provided is a method of inducing a phase transition of a bilayer membrane vesicle, the method including the step of adding a dehydrating condensing agent or a dehydrating condensing agent precursor having the property of accumulating at an interface to the bilayer membrane vesicle. By causing the lipids that form a molecular aggregate to chemically change, it is possible to change the physical property and the morphology of the molecular aggregate and control the timing of phase transitions such as membrane fusion. In the membrane fusion, for example, fusion can occur without leakage of the contents of the bilayer membrane vesicle. | 2013-09-26 |
20130251790 | Low Dose Pharmaceutical Composition Comprising Zanamivir - The present invention provides a pharmaceutical composition comprising a low dose of zanamivir and a process for preparing the pharmaceutical composition comprising a low dose of zanamivir. The pharmaceutical composition comprising a low dose zanamivir may be used in the treatment and/or prophylaxis of influenza. The present invention also provides a method of treatment and/or prophylaxis of influenza which comprises administering a dry powder inhaler composition comprising a low dose zanamivir. The pharmaceutical composition of the present invention comprises zanamivir and one or more pharmaceutically acceptable excipients, wherein the total daily dose of the zanamivir is less than 10 mg, preferably for administration at least once a day, and preferably wherein the composition delivers from 3 mg to 8 mg of zanamivir per administered dose. | 2013-09-26 |
20130251791 | COMPOSITION COMPRISING A BENZIMIDAZOLE AND PROCESS FOR ITS MANUFACTURE - The invention provides new benzimidazole compositions, comprising: (a) a core containing said benzimidazole active ingredient; (b) an intermediate layer; and (c) an enteric layer; said core being substantially free of binder. The invention also provides a process for manufacturing the composition of the invention. | 2013-09-26 |
20130251792 | ENCAPSULATION OF HEAT AND MOISTURE SENSITIVE SUBSTANCES - The present invention relates to a method for preparing a suspension for the encapsulation of heat and moisture sensitive substances in capsules, sachets, droplets and food compositions. It also relates to methods for encapsulating, to the encapsulated products and to methods for storing the encapsulated products. The invention is extremely suitable for the encapsulation of microbial cultures. Cultures encapsulated in capsules prepared according to the method of the invention, will stay stable for a long time. At 25 degrees C. they show a stability reduction of less than 1 log per month. | 2013-09-26 |
20130251793 | PHARMACEUTICAL COMPOSITION COMPRISING PHENTERMINE AND TOPIRAMATE - This invention relates to a pharmaceutical composition comprising a combination of phentermine in an immediate-release form and topiramate in an extended-release form. Further, it relates to processes for the preparation of the composition and a method of using the composition. | 2013-09-26 |
20130251794 | Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same - The present invention relates to a method for “hot melt coating” of pharmaceutical active ingredients characterized by organoleptic or physicochemical properties that it is desirable to mask. | 2013-09-26 |
20130251795 | PHARMACEUTICAL COMPOSITIONS CONTAINING A BIGUANIDE AND A LOW DOSE ANTIDIABETIC AGENT - The present invention relates to pharmaceutical compositions that include a combination of a biguanide present in an extended-release form and a low dose antidiabetic agent present in an immediate-release form. The present invention further relates to processes for preparing such compositions. | 2013-09-26 |
20130251803 | ONCE DAILY FORMULATION OF LACOSAMIDE - A modified release formulation of lacosamide suitable for once-daily administration. | 2013-09-26 |
20130251804 | METHOD TO IMPROVE THE SAFETY OF HANDLING OF HIGH POTENCY DRUGS IN SOLID DOSAGE FORMS WITHOUT CHANGING THEIR EFFICACY - A method to improve the safety of handling of drug substances that are dispensed as solid oral dosage forms is described that does not alter the drug-release profile and the therapeutic efficacy of the pharmaceutical product. | 2013-09-26 |
20130251805 | LOW VISCOSITY LIQUID DOSAGE FORMS - The present invention relates to liquid dosage forms of nanoparticulate active agents having very low viscosities. | 2013-09-26 |
20130251806 | NATURAL BIOCOMPOSITE POWDER PREPARED FROM PICHIA PASTORIS BIOMASS, METHOD OF PREPARATION AND ITS USE AS EXCIPIENT - The present invention concerns a natural biocomposite powder prepared from the biomass of yeast | 2013-09-26 |
20130251807 | MICRONIZED TANAPROGET, COMPOSITIONS, AND METHODS OF PREPARING THE SAME - The present invention provides compositions, desirably pharmaceutical compositions, containing micronized tanaproget. The compositions can also contain microcrystalline cellulose, croscarmellose sodium, anhydrous lactose, magnesium stearate, micronized edetate calcium disodium hydrous, and micronized sodium thiosulfate pentahydrate. The compositions are useful in contraception and hormone replacement therapy and in the treatment and/or prevention of uterine myometrial fibroids, benign prostatic hypertrophy, benign and malignant neoplastic disease, dysfunctional bleeding, uterine leiomyomata, endometriosis, polycystic ovary syndrome, and carcinomas and adenocarcinomas of the pituitary, endometrium, kidney, ovary, breast, colon, and prostate and other hormone-dependent tumors, and in the preparation of medicaments useful therefor. Additional uses include stimulation of food intake. | 2013-09-26 |
20130251808 | PHARMACEUTICAL COMPOSITION, METHOD OF PREPARATION AND METHODS OF TREATING ACHES/PAINS - Provided are methods and compositions useful for treating/aches and/or pains. The composition includes ibuprofen and arginine in a clear stable aqueous ethanol vehicle that is stable at room temperature for at least 6 months without separation or precipitation. The composition is effective for delivering ibuprofen directly through the mucosal or buccal tissue without passing through the GI tract. | 2013-09-26 |
20130251809 | Polyamine Derivatives - Disclosed are compounds, compositions and methods for systemic and local delivery of biologically active molecules. | 2013-09-26 |
20130251810 | PROCESS FOR PREPARING ORALLY ADMINISTERED DABIGATRAN FORMULATIONS - The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I | 2013-09-26 |
20130251811 | METHOD FOR MANUFACTURING MEDICINAL COMPOUNDS CONTAINING DABIGATRAN - The invention relates to an improved process for preparing a new medicament formulation of the active substance dabigatran etexilate of formula I | 2013-09-26 |
20130251813 | FORMULATION OF LACOSAMIDE - A modified release formulation of lacosamide. | 2013-09-26 |
20130251814 | MAGNETIC NANODRUG FOR TREATING THROMBOSIS - The present invention discloses a magnetic nanodrug for treating thrombosis, which comprises a core formed of magnetic nanoparticles, a shell enveloping the core and made of carboxyl-functionalized polyaniline, and a thrombosis-treatment drug covalently bonded to the shell. The magnetic nanodrug of the present invention is non-toxic to vascular endothelial cells, has superior stability, features superparamagnetism, and can be uniformly dissolved in water. Therefore, the magnetic nanodrug for treating thrombosis can be guided by an external magnetic field to concentrate on a specified region and increase the effect of thrombosis treatment. | 2013-09-26 |
20130251815 | COMPOSITIONS AND METHODS FOR ORAL DELIVERY OF ENCAPSULATED DIETHYLENETRIAMINEPENTAACETATE PARTICLES - The present disclosure is directed to compositions comprising encapsulated particles of diethylenetriaminepentaacetate (DTPA) and a zinc salt such as zinc acetate, and to pharmaceutical compositions comprising such encapsulated compositions. The present disclosure is also directed to methods of treatment by administering an effective amount of the compositions and pharmaceutical compositions of the present disclosure, to methods of making such encapsulated particle compositions, and to methods of making the corresponding pharmaceutical compositions. | 2013-09-26 |
20130251816 | CANCER CELL TARGETING USING NANOPARTICLES - The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. Other aspects of the invention are directed to methods using nanoparticle libraries. | 2013-09-26 |
20130251817 | CANCER CELL TARGETING USING NANOPARTICLES - The present invention generally relates to polymers and macromolecules, in particular, to polymers useful in particles such as nanoparticles. One aspect of the invention is directed to a method of developing nanoparticles with desired properties. In one set of embodiments, the method includes producing libraries of nanoparticles having highly controlled properties, which can be formed by mixing together two or more macromolecules in different ratios. One or more of the macromolecules may be a polymeric conjugate of a moiety to a biocompatible polymer. In some cases, the nanoparticle may contain a drug. Other aspects of the invention are directed to methods using nanoparticle libraries. | 2013-09-26 |
20130251818 | PERSONAL LUBRICANTS - Personal lubricants containing royal jelly, a glow powder or xylitol are provided. | 2013-09-26 |
20130251819 | Method of Reducing Microbes on Food - An antimicrobial composition useful for microbial reduction on food includes an oxidizer and an acid component. The oxidizer includes hydrogen peroxide and/or peroxyacetic acid. The acid component includes one or more inorganic acids or their salts. For example, the acid component may be selected from sodium acid sulfate, sulfuric acid, hydrochloric acid, phosphoric acid, sulfamic acid, nitric acid, hydrofluoric acid, or combinations thereof. In certain embodiments, the antimicrobial composition additionally includes one or more surfactants. A method of reducing microbes on food includes applying to the food the above-described antimicrobial composition. | 2013-09-26 |
20130251820 | Alpha-Keto Alkylperacids and Methods For Producing and Using the Same - The present invention provides α-keto alkylperacids and methods for producing and using the same. In particular, α-keto alkylperacids are useful as antimicrobial agents. | 2013-09-26 |
20130251821 | VEGF-ACTIVATED FAS LIGANDS - The present invention provides fusion proteins comprising an extracellular domain of a VEGF receptor and a death ligand. The fusion proteins bind to VEGF and to death receptors on tumor cells thereby inhibiting VEGF activation of VEGF receptors and inducing apoptosis in the tumor cells. Fusion proteins of the present invention are useful for inducing apoptosis and cytotoxic effects in cells, treating cancer and diseases or disorders related to unregulated angiogenesis and/or vasculogenesis. Thus, this invention further provides methods for treating angiogenesis related diseases using the fusion proteins, polynucleotides encoding the fusion proteins, vectors containing the polynucleotides, pharmaceutical compositions and kits containing the fusion proteins or the polynucleotides encoding the fusion proteins. | 2013-09-26 |
20130251822 | BIOCIDAL ALDEHYDE COMPOSITION - A combination biocide (Glutaraldehyde or OPA), quaternary phosphonium biocide, alcohol, and functional excipients for surface-sterilization of medical instruments and other objects. The quaternary phosphonium biocide is preferably TTPC, and the alcohol isopropyl alcohol. The OPA is the dialdehyde C | 2013-09-26 |
20130251823 | ANGIOGENESIS REGULATING COMPOSITION AND METHOD FOR REGULATING ANGIOGENESIS - An angiogenesis regulating composition used to treat/prevent an angiogenic disease in a subject, that contains in an effective amount at least one of nitrate, nitrite, and a compound convertible into nitrate or nitrite after the compound is absorbed into the subject, and an angiogenesis regulation method administering to a subject a composition containing as an active ingredient at least one of nitrate, nitrite, and a compound convertible into nitrate or nitrite after the compound is absorbed into the subject, provide a composition effective in treating and preventing angiogenic diseases, that can medically control angiogenic diseases, and medically regulate angiogenesis in ophthalmologic diseases in particular, and allows treatment without inhibiting physiological neovascularization, with a limited side effect and significantly safely, and an angiogenesis regulation method using the same. | 2013-09-26 |
20130251824 | Recycling cannabinoid extractor - A process and apparatus for extracting cannabinoids from | 2013-09-26 |
20130251825 | Compositions and methods for treatment of mammalian skin - Compositions useful for treatment of a wide range of skin disorders including: pre-cancerous lesions, keratotic lesions, superficial basal cell carcinomae; squamous cell carcinomae; malignant melanoma, and radiation-induced burns. In some embodiments the treatments comprise contacting human or other mammalian skin with a composition according to the disclosure. In other embodiments, administration of compositions provided is by injection. Some embodiments provide for preventive use of compositions provided towards preventing some forms of skin cancer and skin cancer-related disorders by repeated application to healthy-looking skin. Methods for providing the compositions are disclosed. | 2013-09-26 |
20130251826 | Use of Extracts or Materials Extracted From Piper Cubeba L. as an Effective Component in a Drug for the Treatment of Cancer Diseases - The present invention is directed to the use of extracts or of extract compounds from | 2013-09-26 |
20130251827 | COSMETIC COMPOSITION FOR SKIN MOISTURISATION COMPRISING PINE-RESIN EXTRACT, PINUS DENSIFLORA NEEDLE EXTRACT AND PINUS DENSIFLORA ROOT EXTRACT - The present invention relates to a skin moisturizing cosmetic composition that includes a pine resin extract, a | 2013-09-26 |
20130251828 | Lipophilic Carrier Composition for Solubilizing Lipophilic Bioactive Botanical Extracts, Methods of Solubilizing Lipophilic Bioactive Botanical Extracts, and Methods of Using Solubilized Lipophilic Bioactive Botanical Extracts - A lipophilic carrier composition comprising a lipophilic bioactive botanical extract, a vegetable oil, a solubilization system, and, optionally, an antioxidant, where the vegetable oil is present in a stable, relatively unoxidized state, is provided. Also provided is a lipophilic antioxidant composition comprising an antioxidant, a vegetable oil, and a solubilization system, but not comprising a lipophilic bioactive botanical extract, where the vegetable oil is present in a stable, relatively unoxidized state. Disclosed are methods of using the compositions to treat and/or protecting skin against erythema and/or skin barrier function loss as well as methods of using the compositions to treat age spots. | 2013-09-26 |
20130251829 | PROBIOTIC DERIVED NON-VIABLE MATERIAL FOR INFECTION PREVENTION AND TREATMENT - A composition comprising a culture supernatant from a late-exponential growth phase of a batch-cultivation process for a probiotic such as LGG, for use in the treatment or prevention of infection by a pathogen such as | 2013-09-26 |
20130251830 | THERAPEUTIC TREATMENTS USING BOTULINUM NEUROTOXIN - Methods for treating a coronary risk factor (such as hypertension, diabetes, hyperlipidemia and obesity) and/or a respiratory disorder (such as asthma, chronic obstructive pulmonary disease and bronchitis) and/or arthritis by local administration of a botulinum neurotoxin to at least one of a head, neck or shoulder location (for example, by subdermal, subcutaneous or intramuscular administration of the botulinum neurotoxin) of a patient with a coronary risk factor, respiratory disorder or arthritis. | 2013-09-26 |
20130251831 | WINDSHIELD REPAIR APPARATUS - A windshield repair apparatus includes a bridge for holding an injector adjacent to a break area of a windshield. The bridge includes a suction cup for mounting the bridge to the windshield. An articulating arm mounts to the bridge for holding equipment, such as a flashlight, a tool holder, and/or a sun blocker. The bridge includes a pivotally mounted arm which allows for pivotal movement of the injector away from the break area, and a registration system which allows for accurate replacement of the injector over the break area following pivotal movement back toward the break area. The arm also is pivotally moveable toward and away from the windshield and is controlled by a threaded adjustment mechanism. The injector is also threadably adjustable vertically relative to the windshield. The articulating arm includes a quick connect/disconnect feature. | 2013-09-26 |
20130251832 | TIRE VULCANIZER - Provided is a tire vulcanizer capable of adjusting the height of an upper mold attaching member or a lower mold attaching member while fixing the position of the upper mold attaching member or the lower mold attaching member, with a simple structure. A tire vulcanizer ( | 2013-09-26 |
20130251833 | EXTRUSION DEVICE IN PARTICULAR FOR PLASTIC MATERIALS - An extrusion device, in particular for plastic materials comprising: an extrusion head ( | 2013-09-26 |
20130251834 | FIELD EMISSION DEVICE AND NANOFIBER MANUFACTURING DEVICE - Disclosed herein is a field emission device which makes it possible to reliably mass-produce nanofibers having satisfactory quality, even if field emission is conducted in such a way that high voltage is applied to a collector while a nozzle block is grounded. The field emission device includes a collector ( | 2013-09-26 |
20130251835 | FUEL TANK OPENING - Methods and apparatuses for blow molding a fuel tank with multiple concentric needles to form an opening in the fuel tank, and/or for calibrating the opening in the fuel tank as it cools. | 2013-09-26 |
20130251836 | INJECTION MOLDING MACHINE - An injection molding machine is provided that includes a clamping force sensor that detects a clamping force of a mold, and a clamping force monitoring unit that monitors a detected value of the clamping force sensor and calculates a first mold open distance and/or a second mold open distance. The first mold open distance is calculated based on the difference between the maximum value of the detected values obtained during an injection process and a pressure holding process and the detected value obtained at the start of the injection process. The second mold open distance that is calculated based on the difference between the detected value obtained at the end of the pressure holding process and the detected value obtained at the start of the injection process. | 2013-09-26 |
20130251837 | INJECTION MOLDING MACHINE - An injection molding machine including an ejector unit configured to eject a molding product from a mold, wherein the ejector unit includes a slide base freely movable relative to a toggle support disposed at a platen supporting the mold, a toggle mechanism configured to connect the toggle support and the slide base, disposed between the toggle support and the slide base, a driving source configured to operate the toggle mechanism in such a way that a distance between the toggle support and the slide base is changed, and an ejection member movable in conjunction with the slide base. | 2013-09-26 |
20130251838 | FIELD EMISSION DEVICE AND NANOFIBER MANUFACTURING DEVICE - Disclosed herein is a field emission device which makes mass-production of nanofibers having satisfactory performance possible. The field emission device ( | 2013-09-26 |
20130251839 | Device for Dry-Forming a Fibrous Web - A device for dry-forming a fibrous web, in which a plurality of fibers or fiber mixtures is supplied to a forming head by means of an air flow, is described. The forming head includes a forming outlet arranged above a gas-permeable deposit belt. The fibers deposited on the deposit belt within a forming zone are continuously conveyed out of the forming zone by the deposit belt. A clearance of the forming zone formed between the forming head and the deposit belt is shielded with respect to the surroundings by several sealing means. To obtain as uniform a composition of the fiber layer as possible when depositing the fibers, the sealing means arranged on a feed side forms an inlet opening having an adjustable inflow cross-section through which a defined secondary air flow flows from the surroundings into the clearance. | 2013-09-26 |
20130251840 | Pre-Stretcher Assembly and Thermoforming Device - The present invention relates to a pre-stretcher assembly and a thermoforming device. The invention makes use of conical screw thread in combination with a stop so as to obtain a coupling system which can be coupled more quickly, results in a constant coupling and is less susceptible to wear. This makes the invention particularly advantageous for assemblable mould parts having a product-forming function, such as a pre-tensioner. | 2013-09-26 |
20130251841 | Mold Valve - There is provided an improved valve mechanism for use with a casting or injection mold which is quick acting and simple to construct. The valve includes an inlet coupled to the mold cavity and an outlet for venting gas from the mold cavity. The valve further includes a closure oriented perpendicularly to the inlet and movable between open and closed positions for closing off the outlet. The closure has a central axis and the valve is configured to move the closure into the closed position by directing the melt passing through the inlet to impinge substantially coaxially upon the closure so as to transfer a majority of the momentum of the melt to the closure. | 2013-09-26 |
20130251842 | INJECTION MOLDING MACHINE - An injection molding machine includes an electric ejector configured to eject a molding product from a mold, and an assist actuator configured to assist ejection of the molding product by the electric ejector. | 2013-09-26 |
20130251843 | VALVE GATE SYSTEM - A valve gate assembly comprises a piston that is actuable between a forward position and a rear position and has a piston stop surface and a forward pressure surface. A cylinder has a cylinder stop surface that is disposed to contact the piston stop surface when the piston is in the forward position. The cylinder stop surface is radially outward of at least a portion of the forward pressure surface and a shutoff pin is substantially aligned with the axis. | 2013-09-26 |
20130251844 | OLIGOSACCHARIDE MIXTURE AND FOOD PRODUCT COMPRISING THIS MIXTURE, ESPECIALLY INFANT FORMULA - The invention discloses an oligosaccharide mixture comprising at least one N-acetyl-lactosamine, at least one sialylated oligosaccharide, and at least one fucosylated oligosaccharide. Food product, especially infant formula, comprising said oligosaccharide mixture. | 2013-09-26 |
20130251845 | IMPROVED NUTRITIONAL COMPOSITION, ESPECIALLY FOR INFANTS, WITH PARTICULAR FAT PARTICLES - The present invention provides a process for the manufacture of a dairy product or nutritional formula, such as an infant formula, which has a fat particle distribution with resembles human breast milk The process comprises mixing vegetable fat, protein and carbohydrates in a high shear rotor stator mixer and subsequently subjecting said mixture to homogenization so as to provide a composition with a monomodal fat particle size distribution and a low proportion of fat particles below 1 μm. further aspects of the invention relates to the dairy product or nutritional formula per se and the use of said dairy product or nutritional formula. | 2013-09-26 |
20130251846 | CHEWING GUM BASE CONTAINING POLYFARNESENE AND CHEWING GUM PRODUCTS MADE THERE FROM - A chewing gum base comprises food acceptable polyfarnesene wherein the polyfarnesene has a weight average molecular weight above 100,000 daltons. A chewing gum composition comprises about 5% to about 95% chewing gum base comprising food acceptable polyfarnesene wherein the polyfarnesene has a weight average molecular weight above 100,000 daltons; about 5% to about 95% bulking and sweetening agent; and about 0.1 to about 10% flavoring agent. | 2013-09-26 |
20130251847 | PREPARATION OF SEASONING PRODUCTS - A method for preparing a food seasoning product comprising a solid state fermentation step, an hydrolysis step and a thermal reaction step, wherein the solid state fermentation step, hydrolysis step and thermal reaction step are carried out in the same reaction vessel. | 2013-09-26 |
20130251848 | USE OF GLYCOSIDASE IN PREPARATION OF A MILK PRODUCT - A method for making a milk product (e.g. a yogurt) comprising adding an effective amount of an N-linked glycosidase and/or an O-linked glycosidase to milk. | 2013-09-26 |
20130251849 | CHEMICALLY LEAVENED DOUGH COMPOSITIONS AND RELATED METHODS, INVOLVING LOW TEMPERATURE INACTIVE YEAST - Described are dough compositions and methods of making dough compositions, the dough compositions being chemically leavened and being prepared from ingredients that include a low temperature inactive yeast and a yeast inhibitor; the methods include inactivating the low temperature inactive yeast to inhibit the metabolic activity of the yeast as desired; the compositions and methods can be used, e.g., to prepare refrigerated dough products. | 2013-09-26 |
20130251850 | SYRUP COMPRISING HYDROLYZED WHOLE GRAIN - The present invention relates to syrups comprising a content of sweetening agent above 15% by weight of the syrup, a hydrolyzed whole grain composition and, an alpha-amylase or fragment thereof, which alpha-amylase or fragment thereof shows no hydrolytic activity towards dietary fibers when in the active state, and wherein the syrup has a water activity above 0.6. | 2013-09-26 |
20130251851 | EGG WHITE HYDROLYSATE AND PRODUCTION METHOD THEREFOR - An egg white hydrolysate having a reduced sulfur smell characteristic to egg white and a production method therefor are provided. An egg white hydrolysate having a low hydrogen sulfide content and a reduced sulfur smell can be obtained through a pretreatment step of denaturing egg white by thermally treating a diluted egg white solution under conditions of a pH of 9 to 12 and a temperature of 55° C. to 90° C., the diluted egg white solution having been prepared by diluting 1 part of liquid egg white with 0.4 to 3 parts of water, and a step of performing hydrolysis with a protease. | 2013-09-26 |
20130251852 | REDUCED-FAT NATURAL BUTTER PRODUCT AND METHODS OF MANUFACTURING THE SAME - A method of forming a reduced-fat butter product. The method includes churning cream to create buttermilk and concentrated milkfat. The buttermilk is concentrated to increase solids in the buttermilk by about three times to form a concentrated buttermilk. The concentrated buttermilk is blended with the concentrated milkfat to form a final reduced-fat butter product comprising no more than 60 percent fat. | 2013-09-26 |
20130251853 | MODIFIED AGAVE FOOD AND METHOD OF MAKING SAME - Embodiments of the present disclosure are directed to a method for making agave syrup, the method including, mashing the agave piñas; extracting the inulin from the piñas; monitoring the hydrolysis with an osmometer; hydrolyzing the inulin to create specific saccharide functionality; pH adjusting the syrup to promote and stop hydrolysis; and heating the syrup to a temperature sufficient to deactivate native enzymes. | 2013-09-26 |
20130251854 | FOOD OR BEVERAGE COMPOSITION COMPRISING UNROASTED COFFEE SOLIDS - The present invention relates to a food or beverage composition comprising unroasted coffee solids and arabinogalactans, for example a ready-to-drink beverage. | 2013-09-26 |
20130251855 | AQUEOUS PRODUCT COMPRISING OIL-CONTAINING MICROCAPSULES AND METHOD FOR THE MANUFACTURE THEREOF - The present invention discloses microcapsules that are stable in acidic aqueous systems. The microcapsules may be utilized to protect a hydrophobic substance. The microcapsules may be utilized in acidic food products. The microcapsule include at least one hydrophobic substance and a layer around the at least one hydrophobic substance. The layer includes polysaccharide glycated protein. Methods for producing the microcapsules are also disclosed here. | 2013-09-26 |
20130251856 | EDIBLE WAFER - A chocolate confectionery and a method for manufacturing same chocolate confectionery where the chocolate confectionery has multiple pearls of flavor distributed evenly throughout a base chocolate wafer such that the flavor and consistency of the chocolate confectionery is consistent throughout. In one form of the chocolate confectionery, small pearls of flavor are suspended within the chocolate creating a pleasing flavor balance and mouth feel with overall lower sugar content and higher cocoa content. | 2013-09-26 |
20130251857 | FROSTED CEREAL FOOD AND PRODUCTION METHOD THEREOF - A frosted cereal food containing catechins in an amount of 0.1 mass % or more with respect to the dry mass of the frosted cereal food, wherein the frosted cereal food includes a coating material containing a solid content other than saccharides in an amount of 1 mass % or more, the solid content other than saccharides containing the catechins in an amount of 40 mass % or more. | 2013-09-26 |
20130251858 | COMPOSITION - The invention relates to acidified cocoa nibs, wherein the nibs comprise at least 20 mg/g of polyphenols, preferably more than 30 mg/g of polyphenols, most preferably from 40 to 60 mg/g of polyphenols, cocoa refiner or expeller flakes, liquor, cakes, and cocoa powder obtainable from the nibs and a process for producing cocoa-derived material, comprising the steps of: (i) treating cocoa nibs obtained from beans or seeds which have a higher polyphenol content than fermented cocoa beans with an acid; and (ii) optionally drying the nibs. | 2013-09-26 |
20130251859 | PROCESS FOR PREPARING, PRIOR TO FILLING, A WAFER CORNET, CORNET THUS OBTAINED AND INSTALLATION FOR IMPLEMENTING THE PROCESS - Process for preparing a cornet consisting of a substantially conical wafer ( | 2013-09-26 |
20130251860 | PACKAGE WITH INTEGRATED SPREADING AND CUTTING FUNCTIONALITY - A package for use in holding, dispensing, and spreading a viscous substance, such as a condiment. The package may include a thin-walled rigid planar member with at least one centrally-located opening, a flexible membrane forming a sealed reservoir on one surface and a flexible membrane forming a removable cover over the opening on the opposing surface. The reservoir membrane may be permanently sealed to the rigid planar member about a perimeter that surrounds the perforation. The cover, reservoir membrane and the rigid planar member form a sealed cavity with which to safely store and transport the contents, with the cover being removed for dispensing and spreading purposes. | 2013-09-26 |
20130251861 | COFFEE CAPSULE - The object of the invention concerns a coffee capsule, in particular a Nespresso™-compatible capsule that improves the yield of the product obtained through the use of a depression or concavity on the side where the water and/or steam enters the capsule, using a radial diversion of the flow of the water and/or steam that otherwise would enter along a axis parallel to the axis of the capsule. | 2013-09-26 |
20130251862 | SPHERIFICATION/REVERSE SPHERIFICATION AUTOMATED AND INTEGRATED SYSTEM AND METHOD - An apparatus for producing gelled pearls includes: a housing with at least one opening into which a flavored liquid is provided; external components; and internal components. The external components include: a first ingress port through which a first refill pack is coupled; and a dispenser with tubing through which a processed solution is expelled into a gelling bath. The internal components include: a mixing tank for blending the flavored liquid with the first solution; a first flow valve fluidly coupled with the mixing tank and directing the flavored liquid into and out of the mixing tank; a second flow valve fluidly coupled with the mixing tank and directing flow of a proportional amount of the first solution into the mixing tank; and a microcontroller device. | 2013-09-26 |
20130251863 | Apparatus for Treating Items with Gas - Apparatus for treating items with a treatment gas to decontaminate the items includes a chamber which receives the items. The chamber has a gas inlet in fluid communication with a distribution duct positioned within the chamber. The duct distributes the treatment gas throughout the chamber to prevent gas stratification. The chamber may also have a gas outlet for exhausting the chamber, a treatment gas source providing gas, such as ozone, carbon dioxide, or other treatment gas to the chamber. A vacuum pump is used to lower the pressure within the chamber and a purge pump is used to flush the treatment gas from the chamber upon completion of the treatment. A liquid reservoir is used to maintain a desired humidity within the chamber. A heat exchanger is used to maintain a desired temperature within the chamber, and a fan is used to circulate the treatment gas within the chamber. | 2013-09-26 |
20130251864 | Method for Treating Shell Eggs with Gas - A method for treating shell eggs with a gas includes subjecting the eggs to lower than atmospheric pressure for a period of time, heat for a period of time, and a treatment gas for a period of time. The treatment gas may be ozone at about 8-12% concentration by weight, the treatment temperature may be between 55° C. and 60° C. for about 2-25 minutes, and the atmospheric pressure may be from about 60-81 kPa for about 33 minutes or less. Eggs treated using this method showed a reduction in the concentration of | 2013-09-26 |
20130251865 | Antioxidant Formulations - Antioxidant formulations containing new active molecules with tocopherols are disclosed. The best performing formulas contain extracts of green tea that are oil soluble, extracts of rosemary, extracts of spearmint and tocotrienols. Interestingly, the amount of tocopherols in formulas could be reduced by 50% in this diet when the other actives were increased accordingly. | 2013-09-26 |
20130251866 | Preparation of hops - Embodiments of a method and device for processing hops to insure freshness is disclosed. | 2013-09-26 |
20130251867 | FROZEN FOOD PACKAGE AND METHOD OF USE - A frozen food package and method of producing and using the same is disclosed. The food package includes a bag which is freezable, ovenable and microwaveable. A frozen food assembly within the bag includes food (uncooked, cooked, or partially cooked), preferably an entree. Typically, the food assembly includes a meat, a fruit or vegetable, and a flavoring liquid such as a broth or stock, and may include infused oil or a dairy product. The food is typically embedded in the frozen liquid to facilitate handling and shipping and to align the frozen food with a display window of the bag. Chemical preservatives are not necessary and sauces may be omitted although sauces are not burned in the cooking process. The method typically includes sealing the frozen food in the liquid-impermeable bag and cooking the food in the sealed bag. The resulting dish is a substantial improvement over the well-known precooked frozen meals. | 2013-09-26 |
20130251868 | Method and apparatus for beverage production and dispensing - A beverage concentrate system ( | 2013-09-26 |
20130251869 | PROCESS FOR THE MANUFACTURE OF AERATED FROZEN CONFECTIONS - A process for the manufacture of an aerated frozen confection comprising the steps of: preparing an aqueous mix having at least 1 wt % non fat milk solids: homogenising and optionally pasteurising the mix; partially freezing and aerating the mix to an overrun of from 50 to 200%; and extruding the resulting aerated frozen confection in a screw extruder at a temperature of less than −8° C., characterised in that the partially frozen and aerated mix has a pH of from 2.0 to 3.4 is provided. | 2013-09-26 |
20130251870 | DEVICES AND METHODS FOR DEHULLING BEANS AND MAKING SOYMILK - The present invention discloses a device for dehulling beans, a method of dehulling beans, an apparatus for making soymilk and a method of making soymilk. The device for dehulling beans may comprise a driving motor ( | 2013-09-26 |
20130251871 | Food Product Steamer and Method - A food product steamer and method of producing a steamed food product are provided. The food product steamer includes rotatable platforms that can be covered and uncovered by one or more rotatable, concave hoods. In a first position for the platform(s), the plafform(s) supports a food product over a steam-emitting opening above a steam generator. In a first position for the hood, the hood covers the food product such that steam from the steam generator is trapped within the hood to steam the food product. In a second, open position, the hood is rotated where it can receive the food product when the food product slides or falls off the platform as the platform is rotated from its first position to a second, elevated position. At least one embodiment enables food products to be removed from either side of the steam generating base by using a double-acting hinge. | 2013-09-26 |
20130251872 | 3-D Continuous Shaping of Edible-Based Extrudates - A chew toy of non-uniform shape may be manufactured from an edible starch composition by introducing said composition to an extruder having a barrel and subjecting the composition to shear and heat to form a melt, and conveying the melt through an adjustable orifice while varying the cross-section dimensions of the orifice to form an extrudate having thickness dimensions that varies along its length. This may be followed by cutting the extrudate to length. The extrudate may also be passed between cooperating cavities and formed to shape. The extrudate may also be guided into predetermined patterns by repositioning the die relative to a molding surface. | 2013-09-26 |
20130251873 | Reduced Sugar Citrus Juice Beverage - Citrus juice beverage products and their method of production are formulated to reduce the sugar content of the beverage while the beverage products have sensory, taste, mouth feel and texture characteristics that mimic those of whole citrus juice. Orange juice beverage products are especially preferred. The beverage products have a relatively low Brix, on the order of between about 7 and about 8 Brix. Also included in the beverage products is a sweetener which does not add a significant caloric load to the beverage product. A sinking pulp added to the beverage product in an amount to achieve texture and other sensory characteristics of a whole juice. | 2013-09-26 |
20130251874 | Composition Comprising An Extract From Sweet Blackberry Leaves - The present invention relates to a composition comprising at least one extract from sweet blackberry leaves and at least one extract or isolate comprising an isoprenoid; a food or beverage product comprising the composition and the use of the composition as a flavor enhancer, sweetness enhancer or masking agent. | 2013-09-26 |
20130251875 | PROCESS FOR PRODUCTION OF FRIED NOODLES - Fried noodles of excellent quality that are approximately 1 to 7 cm in length can be produced efficiently by a process for production of fried noodles including: a step of preparing raw noodles; a step of gelatinizing the raw noodles; a step of cutting the gelatinized raw noodles into noodles of 1 to 7 cm; and a step of frying the cut noodles by allowing the same to naturally float in frying oil. | 2013-09-26 |
20130251876 | PROCESS FOR PRODUCING INSTANT NOODLES - A process for producing noodle strips in which a dough sheet is slit into noodle strips using a rotary slitting device comprising at least a pair of cutting blade rolls, scraping members and air flow supply means. The dough sheet is passed through the cutting blade rolls, to thereby slit the dough sheet into noodle strips; the noodle strips are peeled off from the cutting blade rolls using the scraping members, to thereby separate into upper and lower noodle strip bundles; and air flow is supplied to the slit noodle strips from the air flow supply means. There is provided a process capable of stably realizing generally straight noodle strips with no strong longitudinal waves even in a mass production line. | 2013-09-26 |
20130251877 | SNACK PRODUCTS AND METHOD FOR PRODUCING SAME - Snack products and methods for producing snack products comprising a mixture of an expandable base product and one or more relatively non-expandable inclusions. The base product may comprise a pelletized or non-pelletized wheat, potato, corn, rice, other flours, starches, and grains, vegetables, and/or mixes thereof. The inclusions may comprise one or more types of herbs and spices, vegetables, fruits, meats, beans, grains, or other ingredients. The mixture is processed using an expansion machine (or “puffing machine”) that is operative to cook and expand the mixture to form a snack product, such as a chip, cracker, cake, or the like. | 2013-09-26 |
20130251878 | FOAMING TEA COMPOSITIONS - The present invention relates to a simple foaming tea composition with a viscosity, clarity or color of the original tea. In one aspect, the invention relates to a foaming tea composition comprising a tea product, a food grade ester alginate, wherein the addition of ester alginate generates or produces a layer of foam upon the tea product when subjected to agitation without also producing a significant change in viscosity, clarity or color of the tea product. In some embodiments, the ester alginate is a synthetic ester alginate, such as propylene glycol alginate ester. In some embodiments, the ester alginate comprises from about 0.01% to about 0.25%, and preferably from about 0.05% to about 0.1% of the foaming tea composition. The present invention also relates to a method of making a foaming tea composition by combining a tea product with an alginate ester. | 2013-09-26 |